Cargando…
Synthesis and biological evaluation of niclosamide PROTACs
Roughly 268,000 new cases of prostate cancer and 34,000 deaths from prostate cancer are projected by the American Cancer Society to occur in the United States in 2022. Androgen receptor is a key protein in the proliferation and survival of prostate cancer cells and has been revealed to be overexpres...
Autores principales: | Munoz, Erick, Chen, Guanglin, Hossain, Ahamed, Wu, Sitong, Nava, Esveidy Oceguera, Hang, Jasmine, Lee, Tong, Zhang, Qiang, Wang, Guangdi, Chen, Qiao-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729070/ https://www.ncbi.nlm.nih.gov/pubmed/35772635 http://dx.doi.org/10.1016/j.bmcl.2022.128870 |
Ejemplares similares
-
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023) -
3-O-Carbamoyl-5,7,20-O-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation
por: Wu, Sitong, et al.
Publicado: (2021) -
New Zampanolide Mimics: Design, Synthesis, and Antiproliferative Evaluation
por: Chen, Guanglin, et al.
Publicado: (2020) -
Core Structure–Activity Relationship Studies of 5,7,20-O-Trimethylsilybins in Prostate Cancer Cell Models
por: Wu, Sitong, et al.
Publicado: (2023) -
Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs
por: Qin, Qiaohua, et al.
Publicado: (2022)